0001570562-18-000044.txt : 20180531
0001570562-18-000044.hdr.sgml : 20180531
20180531161535
ACCESSION NUMBER: 0001570562-18-000044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180529
FILED AS OF DATE: 20180531
DATE AS OF CHANGE: 20180531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SILVERNAIL LAUREN P
CENTRAL INDEX KEY: 0001225755
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38381
FILM NUMBER: 18871770
MAIL ADDRESS:
STREET 1: 15279 ALTON PARKWAY
STREET 2: SUITE #100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolus, Inc.
CENTRAL INDEX KEY: 0001570562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461385614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17901 VON KARMAN AVENUE, SUITE 150
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: (949) 284-4555
MAIL ADDRESS:
STREET 1: 17901 VON KARMAN AVENUE, SUITE 150
CITY: IRVINE
STATE: CA
ZIP: 92614
4
1
wf-form4_152779767553759.xml
FORM 4
X0306
4
2018-05-29
0
0001570562
Evolus, Inc.
EOLS
0001225755
SILVERNAIL LAUREN P
17901 VON KARMAN AVE, SUITE 150
IRVINE
CA
92614
0
1
0
0
See Remarks
Common Stock
2018-05-29
4
A
0
30000
0
A
30000
D
Stock Option (Right to Buy)
22.44
2018-05-29
4
A
0
200000
0
A
2028-05-29
Common Stock
200000.0
200000
D
Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 29, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 29, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
Chief Financial Officer and Executive Vice President, Corporate Development
/s/ Jeffrey J. Plumer, as attorney-in-fact for Lauren Silvernail
2018-05-31